Preface -- Effects of Exposure to Carbon Dioxide in Potash Miners -- B Cell-Attracting Chemokine-1 and Progranulin in Bronchoalveolar Lavage Fluid of Patients with Advanced Non-Small Cell Lung Cancer: New Prognostic Factor -- Paraoxonase 1 Gene L55M Polymorphism and Paraoxonase 1 Activity in Obstructive Sleep Apnea Patients -- Adaptation to Hypoxia in Sleep Apnea Patients: Multifaceted Mechanisms -- Mandibular Advancement Devices in Obstructive Sleep Apnea Patients Intolerant to Continuous Positive Airway Pressure Treatment -- Simvastatin Therapy and Bronchoalveolar Lavage Fluid Biomarkers in Chronic Obstructive Pulmonary Disease -- Influence of Socio-Economic Status on Lung Function in Male Adolescents in Tanzania -- Unmet Needs and Pro-health Behavior in Patients with Chronic Respiratory Diseases -- Circulation of Influenza Virus in the 2015/2016 Epidemic Season in Poland: Serological Evaluation of Anti-Hemagglutinin Antibodies -- Respiratory Viruses in Different Provinces of Poland during the Epidemic Season 2016/2017 -- Index.

This book presents original articles that report on new approaches and developments involving pulmonary disorders. Pulmonary heath diseases public concern as lungs are the first line of defense of the organism against various contagions and are directly influenced by all too often unhealthy constituents of ambient air, which make them vulnerable to diseases. The articles deal with the pathogenic background and most relevant practical aspects of the widespread pulmonary disorders. Topics include the mechanisms and treatment options of sleep apnea syndrome, occupational exposure to carbon dioxide, and the research on prognostic factors in lung cancer. Another theme tackles quality of life in chronic pathologies and the psychosocial factors, often underestimated, having influence on lung function already in adolescence, and thus liable to shape adult pulmonary morbidity. Reports on the course of recent influenza outbreaks and a rather dismal state of anti-influenza measures top off the content. The volume is addressed to clinicians and researchers, pulmonary doctors, and other professionals engaged in patient care and therapy.